Taiwan Liposome Company's IPO

Taiwan Liposome Company raised a round of funding on April 27, 2018. Investors include Public.

Taiwan Liposome Company (TLC) is a biopharmaceutical company engaging in research, development and commercialization of proprietary drug delivery system for improving the treatment of cancer, ophthalm…

Articles about Taiwan Liposome Company's IPO: